Research suggests that the available published evidence directly examining Kanna (Sceletium tortuosum) for anxiety relief is extremely limited in this set of sources. The single study provided is a review focused on agomelatine, a pharmaceutical antidepressant, and its effects on anxiety symptoms in the context of major depressive disorder — it does not examine Kanna at all. Studies indicate that drawing any conclusions about Kanna's effectiveness for anxiety relief from this body of evidence would not be possible, as the research presented pertains to an entirely different intervention. Readers interested in Kanna specifically should seek out studies that directly investigate Sceletium tortuosum, as the current source base does not support any summary of its effects on anxiety.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Dep... | Other | 2023 | Neutral | 72 |